Purdue Pharma Settles Oklahoma Opioid Suit for $270 Million (3)

March 26, 2019, 12:17 PM UTCUpdated: March 27, 2019, 1:28 PM UTC

Purdue Pharma LP and the Sackler family will pay $270 million to settle Oklahoma’s claims that illegal marketing of the Oxycontin painkiller devastated local communities, an accord that could influence the results of thousands of lawsuits faced by the company and others.

The settlement comes two months before the scheduled start of a trial against Purdue, Johnson & Johnson and Teva Pharmaceutical Industries Ltd. and other opioid makers in Norman. Oklahoma is the first state in the nation to try such claims and the trial against the other companies will proceed.

The settlement resolves a sliver of the massive legal ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.